Zinc as a protective factor against COPD: Insights from observational and Mendelian randomization analyses.

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as an observational study.

MR analyses were conducted to assess causality, with sensitivity tests ensuring robustness.

Why It Was Studied

Zinc, a key micronutrient, plays critical roles in immune regulation, anti-inflammatory processes, and maintaining epithelial integrity, yet its relationship with COPD and related infections remains poorly understood.

This study utilized data from the National Health and Nutrition Examination Survey and Mendelian randomization (MR) analyses.

Who Took Part

According to the abstract, 67,502 participants were involved.

By PubMed's age tags, the people studied were adults, middle-aged adults and older adults, both men and women.

Serum zinc levels were assessed in 67,502 participants, with COPD diagnosed based on forced expiratory volume in 1 second/forced vital capacity <0.70 or physician reports.

What Was Measured

PubMed files the paper under topics including Pulmonary Disease, Chronic Obstructive, Mendelian Randomization Analysis, Zinc, Protective Factors, Nutrition Surveys, Smoking and Risk Factors.

The authors tagged it with the keywords COPD, micronutrients and restricted cubic spline.

What This Means in Plain Language

This is an observational study of Vitamin D, K2, Magnesium and Zinc in 67,502 participants.

With several hundred people or more, it is a fairly large study for this kind of research.

The publication is from 2025 (Medicine), a journal based in United States.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.